Cargando…

Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy

Introduction: Intravenous contrast agents can cause acute decline in kidney function, especially in patients with risk factors. Objectives: In this study, we aimed to examine the ameliorative effect N-acetylcysteine (NAC) to reduce the incidence of contrast nephropathy. Patients and Methods: This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pezeshgi, Aiyoub, Parsamanesh, Negin, Farhood, Goodarz, Mahmoodi, Khalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nickan Research Institute 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685979/ https://www.ncbi.nlm.nih.gov/pubmed/26693496 http://dx.doi.org/10.12861/jrip.2015.23

Ejemplares similares

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Richter, Sara K., et al.
Publicado: (2015)

Bioimpacts of dialyzer variety on phosphorus level in Iranian hemodialysis patients
por: Pezeshgi, Aiyoub, et al.
Publicado: (2016)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Arabmomeni, Morteza, et al.
Publicado: (2015)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Publicado: (2009)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials
por: Sun, Zikai, et al.
Publicado: (2013)

Effectiveness of N‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Xu, Renfan, et al.
Publicado: (2016)

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis
por: Li, Jing-Xiu, et al.
Publicado: (2017)

Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials
por: Zhu, Rong, et al.
Publicado: (2023)

Prophylaxis of contrast-induced nephropathy in patients with impaired renal function: double-blind comparison of acetylcysteine, theophylline, acetylcysteine + theophylline and placebo
por: Huber, W, et al.
Publicado: (2005)

Effect of low dose nebulized morphine on respiratory function improvement in mustard gas-exposed patients: A double-blind crossover clinical trial study
por: Ghodrati, Samad, et al.
Publicado: (2022)

N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study
por: Poletti, Pierre-Alexandre, et al.
Publicado: (2013)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study
por: Palli, Eleni, et al.
Publicado: (2017)

Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast‐Induced Nephropathy: A Failure of Academic Clinical Science
por: Sandilands, Euan A., et al.
Publicado: (2022)

Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
por: Biernacka-Fiałkowska, Barbara, et al.
Publicado: (2018)

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
por: Bagshaw, Sean M, et al.
Publicado: (2004)

Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint
por: Moghimi, Minoosh, et al.
Publicado: (2016)

Prevalence and risk factors of urinary tract infection in kidney recipients: a meta-analysis study
por: Hosseinpour, Masoumeh, et al.
Publicado: (2023)

Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
por: Wang, Chengfen, et al.
Publicado: (2015)

Hyperoxia-induced lens damage in rabbit: protective effects of N-acetylcysteine
por: Wang, Ping, et al.
Publicado: (2009)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
por: Panova, Ina G., et al.
Publicado: (2023)

N-acetylcysteine ameliorates contrast-induced kidney injury in rats with unilateral hydronephrosis
por: Xia, Qiang, et al.
Publicado: (2018)

The Efficacy of Hydration with Normal Saline Versus Hydration with Sodium Bicarbonate in the Prevention of Contrast-induced Nephropathy
por: Mahmoodi, Khalil, et al.
Publicado: (2014)

In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media
por: Lea, Jane, et al.
Publicado: (2014)

N-Acetylcysteine Protects against the Anxiogenic Response to Cisplatin in Rats
por: Vukovic, Rade, et al.
Publicado: (2019)

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
por: Amini, Manouchehr, et al.
Publicado: (2009)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
por: Dósa, Edit, et al.
Publicado: (2017)

Cerebellum Susceptibility to Neonatal Asphyxia: Possible Protective Effects of N-Acetylcysteine Amide
por: Benterud, T., et al.
Publicado: (2018)

Protective Effects of N-Acetylcysteine on Lipopolysaccharide-Induced Respiratory Inflammation and Oxidative Stress
por: Chen, Hongbai, et al.
Publicado: (2022)

Biomarkers in the prediction of contrast media induced nephropathy – the BITCOIN study
por: Seibert, Felix S., et al.
Publicado: (2020)

Histological analysis of the intestinal wall of newborn rats submitted to hypoxia and reoxygenation to evaluate the protective effect of N-Acetylcysteine
por: Silvares, Soraia Guerra, et al.
Publicado: (2020)

Evaluating the Psychiatric Benefits of Formulating Acetaminophen With N-Acetylcysteine
por: Serdenes, Ryan, et al.
Publicado: (2020)

N-acetylcysteine protects hepatocytes from hypoxia-related cell injury
por: Heil, Jan, et al.
Publicado: (2018)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
por: Baetas, João, et al.
Publicado: (2019)

Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression
por: Mitsopoulos, Panagiotis, et al.
Publicado: (2011)

Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model
por: Wang, Qingjing, et al.
Publicado: (2013)

Synergistic protective effect of N-acetylcysteine and taurine against cisplatin-induced nephrotoxicity in rats
por: Abdel-Wahab, Wessam M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bn18oa6478uu1kj1m0ha2n126b